Leathem S. Stearn - 08 May 2025 Form 4 Insider Report for Zeo ScientifiX, Inc. (ZEOX)

Reporting relationship: Director
Issuer ticker: ZEOX
Reported as of: 08 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 May 2025, 16:06:47 UTC
Prior SEC filing: 15 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Leathem S. Stearn

Key filing fact

Leathem S. Stearn filed Form 4 for Zeo ScientifiX, Inc. (ZEOX) on 12 May 2025.

Key facts

This page summarizes Leathem S. Stearn's Form 4 filing for Zeo ScientifiX, Inc. (ZEOX).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 12 May 2025, 16:06.

Change

Previous filing in this sequence was filed on 15 Jul 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001950011 Primary reporting owner

Stearn Leathem S

Relationship: Director
Address: 3321 COLLEGE AVENUE, SUITE 246, DAVIE
Signature: /s/ Leathem S. Stearn
Signature date: 12 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZEOX transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +5,000
Change %
Price: $0.000000
Shares after: 5,000
Date: 08 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $2.86
Footnotes: F1

ZEOX transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +5,000
Change %
Price: $0.000000
Shares after: 5,000
Date: 08 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $2.86
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date.

Footnote F2

Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025.